HENGRUI PHARMA (01276.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec7

Hengrui Medicine's 10 Products Included in the New National Health Insurance Drug List

03:50

Dec2

Hengrui Medicine Initiates Share Repurchase Plan

08:46

Hengrui Medicine's Remimazolam Trometamol Injection Marketing Authorization Application Accepted by NMPA

08:45

Dec1

GIC Private Limited Increases Stake in Hengrui Medicine to 23.03%

12:32

Nov27

Morgan Stanley Buys 1,770,645 Shares of Hengrui Medicine

11:17

Hengrui Medicine Obtains Clinical Trial Approval Notices for Multiple Drugs

09:03

Schedules & Filings

Schedules

Filings

Oct27

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 8.119 B, Net Income 1.422 B, EPS 0.2131

Aug20

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 9.364 B, Net Income 2.82 B, EPS 0.4359

May23

IPO(CST)

Listing Price HKD 44.05

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More